Medexus Pharmaceuticals Inc. (MEDXF)

USD 1.91

(-2.05%)

Annual Balance Sheets

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 155.57 Million 161.32 Million 161.32 Million 139.22 Million 148.51 Million 85 Million
Total Current Assets 72.42 Million 72.96 Million 72.96 Million 49.11 Million 58.57 Million 35.05 Million
Cash And Short Term Investments 5.24 Million 13.06 Million 13.06 Million 10.01 Million 18.7 Million 21.87 Million
Cash and Cash Equivalents 5.24 Million 13.06 Million 13.06 Million 10.01 Million 18.7 Million 21.87 Million
Short Term Investments - - - - - -
Net Receivables 24 Million 22.38 Million 22.38 Million 14.4 Million 18.82 Million 7.44 Million
Inventory 30.74 Million 22.84 Million 22.84 Million 21.35 Million 14.66 Million 4.23 Million
Other Current Assets 12.42 Million 2.29 Million 2.29 Million 1.28 Million 1.66 Million 1.5 Million
Total Non-Current Assets 83.15 Million 88.36 Million 88.36 Million 90.11 Million 89.94 Million 49.95 Million
Net PPE 777.19 Thousand 899 Thousand 899 Thousand 1.22 Million 795 Thousand 649.42 Thousand
Good Will And Intangible Assets 74.41 Million 80.65 Million 80.65 Million 87.25 Million 87.01 Million 48.78 Million
Good Will 10.26 Million 10.28 Million 10.28 Million 10.68 Million 10.65 Million 6.99 Million
Intangible Assets 64.14 Million 70.37 Million 70.37 Million 76.56 Million 76.36 Million 41.78 Million
Long-Term Investments -64.15 Million -9.19 Million -1.64 Million - - -869.21 Thousand
Tax Assets 8.03 Million 6.8 Million 6.8 Million - - 869.21 Thousand
Other Non Current Assets 64.07 Million 9.19 Million 1.64 Million 1.64 Million 2.13 Million 520.42 Thousand
Other Assets - - - - - 1.00
Total Liabilities 125.28 Million 138.88 Million 138.88 Million 121.43 Million 130.49 Million 57.13 Million
Total Current Liabilities 66.16 Million 83.49 Million 83.49 Million 48.1 Million 39.93 Million 10.59 Million
Account Payables 7.74 Million 10.15 Million 10.15 Million 12.04 Million 14.85 Million 3 Million
Tax Payables 1.31 Million 1.18 Million 1.18 Million 27 Thousand 514 Thousand 473.11 Thousand
Short Term Debt 15.72 Million 42.7 Million 42.7 Million 15.04 Million 10.56 Million -
Deferred Revenue 1.31 Million 27.93 Million 27.93 Million 18.38 Million - -
Other Current Liabilities 41.37 Million 2.7 Million 2.7 Million 2.63 Million 14.51 Million 7.58 Million
Total Non Current Liabilities 59.11 Million 55.38 Million 55.38 Million 73.32 Million 90.55 Million 46.54 Million
Long-Term Debt 33.76 Million 27.37 Million 27.37 Million 39.81 Million 34.3 Million 16.87 Million
Deferred Revenue Non Current - - -1.52 Million - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 25.35 Million 28 Million 28 Million 31.98 Million 53.61 Million 24.07 Million
Other Liabilities 1.00 - - - - 1.00
Total Equity 30.29 Million 22.44 Million 22.44 Million 17.79 Million 18.01 Million 27.87 Million
Stock Holders Equity 30.29 Million 22.44 Million 22.44 Million 17.79 Million 18.01 Million 27.87 Million
Common Stock 76.31 Million 69.01 Million 69.01 Million 68.68 Million 66.68 Million 46.39 Million
Retained Earnings -64.17 Million -64.02 Million -64.02 Million -65.24 Million -62.37 Million -25.26 Million
Accumulated other comprehensive income 6.16 Million 6.15 Million 6.15 Million 3.97 Million 4.2 Million 1.05 Million
Common Stock Equity 30.29 Million 22.44 Million 22.44 Million 17.79 Million 18.01 Million 27.87 Million
Capital Lease Obligation 353.63 Thousand 455.3 Thousand 978.91 Thousand 266.44 Thousand 785.19 Thousand -
Total Investments -64.15 Million -9.19 Million -1.64 Million - - -869.21 Thousand
Total Debt 49.84 Million 70.08 Million 70.08 Million 54.86 Million 44.87 Million 16.87 Million
Net Debt 44.59 Million 57.01 Million 57.01 Million 44.84 Million 26.16 Million -5 Million

Balance Sheet Charts